These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8970399)

  • 1. Risk factors for accelerated decline among patients with chronic obstructive pulmonary disease.
    Kerstjens HA; Brand PL; Postma DS
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 2):S266-72. PubMed ID: 8970399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Course of obstructive lung diseases].
    Bakke PS
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):177-81. PubMed ID: 8430396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group.
    Tashkin DP; Altose MD; Connett JE; Kanner RE; Lee WW; Wise RA
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1802-11. PubMed ID: 8665038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of smoking on the decline in forced expiratory volume in one second].
    Sato K; Kioi S; Arakawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Mar; 35(3):288-93. PubMed ID: 9168644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1.
    Rijcken B; Schouten JP; Xu X; Rosner B; Weiss ST
    Am J Respir Crit Care Med; 1995 May; 151(5):1377-82. PubMed ID: 7735588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of chronic obstructive pulmonary disease: the Dutch experience.
    Postma DS; Sluiter HJ
    Am Rev Respir Dis; 1989 Sep; 140(3 Pt 2):S100-5. PubMed ID: 2782755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group.
    Kerstjens HA; Overbeek SE; Schouten JP; Brand PL; Postma DS
    Eur Respir J; 1993 Jun; 6(6):868-76. PubMed ID: 8339808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
    Vestbo J; Prescott E; Lange P
    Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.
    Wise RA
    Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease.
    Hansen EF; Vestbo J; Phanareth K; Kok-Jensen A; Dirksen A
    Am J Respir Crit Care Med; 2001 Mar; 163(3 Pt 1):690-3. PubMed ID: 11254525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
    Islam SS; Schottenfeld D
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.
    Pauwels RA; Löfdahl CG; Laitinen LA; Schouten JP; Postma DS; Pride NB; Ohlsson SV
    N Engl J Med; 1999 Jun; 340(25):1948-53. PubMed ID: 10379018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of noninvasive parameters and pulmonary artery mean pressure in patients with chronic obstructive lung disease.
    Seibold H; Bunjes D; Kohler J; Schmidt A
    Clin Physiol Biochem; 1988; 6(2):106-16. PubMed ID: 3402158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annual change in FEV
    Suzuki M; Makita H; Konno S; Shimizu K; Nasuhara Y; Nagai K; Akiyama Y; Fuke S; Saito H; Igarashi T; Takeyabu K; Nishimura M
    Sci Rep; 2019 Feb; 9(1):2073. PubMed ID: 30765818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intervention in COPD.
    Carveth HJ; Kanner RE
    Compr Ther; 1997 Jan; 23(1):31-7. PubMed ID: 9067080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.
    Tirimanna PR; Den Otter JJ; Van Schayck CP; Van Herwaarden CL; Folgering H; Van Weel C
    Br J Gen Pract; 1996 Jan; 46(402):15-8. PubMed ID: 8745846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary function in first generation children of chronic obstructive pulmonary disease (COPD) patients: assessment of related predicting factors].
    Lu B; He Q; Chen Q; Huang X; Li J
    Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1136-9. PubMed ID: 12425829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal follow-up of lung function from childhood to adolescence in prematurely born patients with neonatal chronic lung disease.
    Koumbourlis AC; Motoyama EK; Mutich RL; Mallory GB; Walczak SA; Fertal K
    Pediatr Pulmonol; 1996 Jan; 21(1):28-34. PubMed ID: 8776263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common lung conditions: chronic obstructive pulmonary disease.
    Delzell JE
    FP Essent; 2013 Jun; 409():23-31. PubMed ID: 23767419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.